Healthcare -
Biotechnology - NASDAQ - GB
$ 2.715
-3.53 %
$ 432 M
Market Cap
-7.03
P/E
MREO - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities MREO - Mereo BioPharma Group plc
46.1 M
LAST VALUE
680.13%
2 YEAR CAGR
58.75%
5 YEAR CAGR
0.00%
10 YEAR CAGR